Murakami-Mori K, Taga T, Kishimoto T, Nakamura S
Institute of Molecular Medicine and Technology, Huntington Memorial Hospital, Pasadena, California 91105, USA.
J Clin Invest. 1995 Sep;96(3):1319-27. doi: 10.1172/JCI118167.
Oncostatin M (OM), which shares functional similarity and structural homology to leukemia inhibitory factor (LIF) and interleukin-6 (IL-6), functions as a potent growth factor for AIDS-associated Kaposi's sarcoma-derived cells (AIDS-KS cells). OM was also suggested to bind to the LIF receptor (LIF/OM receptor), which consists of a signal transducing subunit for LIF and IL-6 (gp130) and a LIF receptor alpha-subunit. Recent studies indicate that IL-6 has growth-stimulating activity for AIDS-KS cells. However, we find that AIDS-KS cell growth is exclusively induced by OM and not by LIF or IL-6. We also observed the lack of binding properties of AIDS-KS cells for LIF and IL-6. Scatchard plots revealed the existence of two affinity classes of OM receptor sites on AIDS-KS cells, with Kd values of 6-12 pM (high affinity) and 521-815 pM (low affinity). In competition binding studies, we find that the OM-specific receptor, but not the LIF/OM receptor, contributes to the OM-specific growth stimulation of AIDS-KS cells. We also noted that anti-gp130 antibodies can completely abolish OM-induced growth stimulation of AIDS-KS cells as well as OM binding to AIDS-KS cells. PCR amplification clearly revealed high levels of gp130 expression in AIDS-KS cells, while the transcript of LIF receptor alpha-subunit or IL-6 receptor alpha-subunit was not observed. Therefore, we conclude that (a) AIDS-KS cells express the OM-specific receptor with high and low affinity, but not the LIF/OM receptor; (b) gp130 on AIDS-KS cells plays a key role in OM binding and signaling on the OM-specific receptor; and (c) the lack of biological response of AIDS-KS cells to IL-6 and LIF can be explained by the absence of the IL-6 and LIF/OM receptors. All this evidence shows the correlation of OM-specific biological activity with expression of the OM-specific receptor and the involvement of gp130 on this receptor, as based on findings in in vitro growth assays and binding experiments for AIDS-KS cells.
抑瘤素M(OM)与白血病抑制因子(LIF)和白细胞介素-6(IL-6)在功能上相似且结构同源,它作为艾滋病相关卡波西肉瘤衍生细胞(艾滋病-卡波西肉瘤细胞)的一种强效生长因子发挥作用。OM还被认为可与LIF受体(LIF/OM受体)结合,该受体由LIF和IL-6的信号转导亚基(gp130)以及LIF受体α亚基组成。近期研究表明IL-6对艾滋病-卡波西肉瘤细胞具有生长刺激活性。然而,我们发现艾滋病-卡波西肉瘤细胞的生长仅由OM诱导,而非LIF或IL-6。我们还观察到艾滋病-卡波西肉瘤细胞对LIF和IL-6缺乏结合特性。Scatchard图显示艾滋病-卡波西肉瘤细胞上存在两类OM受体位点,其解离常数(Kd)值分别为6 - 12 pM(高亲和力)和521 - 815 pM(低亲和力)。在竞争结合研究中,我们发现OM特异性受体而非LIF/OM受体有助于艾滋病-卡波西肉瘤细胞的OM特异性生长刺激。我们还注意到抗gp130抗体可完全消除OM诱导的艾滋病-卡波西肉瘤细胞生长刺激以及OM与艾滋病-卡波西肉瘤细胞的结合。PCR扩增清楚地显示艾滋病-卡波西肉瘤细胞中gp